| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |